Birdwatch Note
2023-12-09 08:16:44 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Der Fachartikel befasst sich nicht mit „bisher unerkannten Problemen von Pfizers modRNA“, sondern mit theoretischen Probleme von mRNA-Therapeutika. Es wurden keine nachteiligen Folgen aus der Fehlübersetzung von mRNA-basierten SARS-CoV-2-Impfstoffen beim Menschen gemeldet. https://www.nature.com/articles/s41586-023-06800-3
Written by 546320A5463D9A58412AA8E79782D6727E120E1139FC78AAF299E6C8B76C8E65
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1733390505730297997
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1733400273958179114
- noteId - 1733400273958179114
- participantId -
- noteAuthorParticipantId - 546320A5463D9A58412AA8E79782D6727E120E1139FC78AAF299E6C8B76C8E65 Participant Details
- createdAtMillis - 1702109804988
- tweetId - 1733390505730297997
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Der Fachartikel befasst sich nicht mit „bisher unerkannten Problemen von Pfizers modRNA“, sondern mit theoretischen Probleme von mRNA-Therapeutika. Es wurden keine nachteiligen Folgen aus der Fehlübersetzung von mRNA-basierten SARS-CoV-2-Impfstoffen beim Menschen gemeldet. https://www.nature.com/articles/s41586-023-06800-3
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-12-09 08:16:44 UTC (1702109804988) |
1969-12-31 23:59:59 UTC (-1) |
2023-12-10 03:45:05 UTC (1702179905692) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-12-09 16:13:44 -0600 | Rating Details | |
| 2023-12-09 15:58:28 -0600 | Rating Details | |
| 2023-12-09 13:52:14 -0600 | Rating Details | |
| 2023-12-09 09:48:43 -0600 | Rating Details | |
| 2023-12-09 09:05:46 -0600 | Rating Details | |
| 2023-12-09 07:39:17 -0600 | Rating Details | |
| 2023-12-09 06:52:07 -0600 | Rating Details | |
| 2023-12-09 06:42:08 -0600 | Rating Details | |
| 2023-12-09 06:23:33 -0600 | Rating Details | |
| 2023-12-09 05:57:35 -0600 | Rating Details | |
| 2023-12-09 05:43:19 -0600 | Rating Details | |
| 2023-12-09 05:24:08 -0600 | Rating Details | |
| 2023-12-09 04:40:05 -0600 | Rating Details | |
| 2023-12-09 04:17:22 -0600 | Rating Details | |
| 2023-12-09 04:10:47 -0600 | Rating Details | |
| 2023-12-09 03:44:28 -0600 | Rating Details | |
| 2023-12-09 03:35:43 -0600 | Rating Details | |
| 2023-12-09 03:35:20 -0600 | Rating Details | |
| 2023-12-09 03:33:37 -0600 | Rating Details | |
| 2023-12-09 03:29:47 -0600 | Rating Details | |
| 2023-12-09 03:26:52 -0600 | Rating Details | |
| 2023-12-09 03:24:39 -0600 | Rating Details | |
| 2023-12-09 03:14:49 -0600 | Rating Details | |
| 2023-12-09 03:13:37 -0600 | Rating Details | |
| 2023-12-09 03:04:59 -0600 | Rating Details | |
| 2023-12-09 03:04:23 -0600 | Rating Details | |
| 2023-12-09 03:03:03 -0600 | Rating Details | |
| 2023-12-09 03:01:26 -0600 | Rating Details | |
| 2023-12-09 02:57:26 -0600 | Rating Details | |
| 2023-12-09 02:55:53 -0600 | Rating Details | |
| 2023-12-09 02:55:07 -0600 | Rating Details | |
| 2023-12-09 02:50:26 -0600 | Rating Details | |
| 2023-12-09 02:49:54 -0600 | Rating Details | |
| 2023-12-09 02:44:37 -0600 | Rating Details | |
| 2023-12-09 02:44:37 -0600 | Rating Details | |
| 2023-12-09 02:43:56 -0600 | Rating Details | |
| 2023-12-09 02:43:50 -0600 | Rating Details | |
| 2023-12-09 02:39:55 -0600 | Rating Details | |
| 2023-12-09 02:36:28 -0600 | Rating Details | |
| 2023-12-09 02:35:34 -0600 | Rating Details | |
| 2023-12-09 02:26:39 -0600 | Rating Details | |
| 2023-12-10 15:34:40 -0600 | Rating Details | |
| 2023-12-10 12:20:18 -0600 | Rating Details | |
| 2023-12-10 09:06:46 -0600 | Rating Details | |
| 2023-12-10 02:12:32 -0600 | Rating Details | |
| 2023-12-10 01:58:38 -0600 | Rating Details | |
| 2023-12-10 00:38:34 -0600 | Rating Details | |
| 2023-12-09 19:33:41 -0600 | Rating Details | |
| 2023-12-09 18:39:43 -0600 | Rating Details | |
| 2023-12-11 09:26:38 -0600 | Rating Details | |
| 2023-12-11 08:03:41 -0600 | Rating Details | |
| 2023-12-15 11:06:13 -0600 | Rating Details | |
| 2023-12-25 07:46:00 -0600 | Rating Details |